HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Eldest Kardashian Sis Launching CBD Serum With Hora Skincare

Executive Summary

Kourtney of the “Keeping Up With” clan has partnered with Hora Skincare to launch Hyaluronic Halo + CBD Serum. Announced 6 September, the $50 product will be available exclusively through Kardashian’s Poosh lifestyle platform.

You may also be interested in...



CBD Pollinating New Beauty Categories With Cannabis Cachet: Sunscreens, Deodorants And More

Cannabidiol (CBD) is spreading from therapeutic skin care to deodorants, sunscreens and makeup products as companies race to meet consumer demand despite regulatory uncertainties and potential legal pitfalls.

Ulta Projects Continuing Makeup Headwinds, Lowers Guidance For Fiscal 2019

Over the fiscal 2019 first half, “we've continued to expand our market share across most categories, increased our brand awareness, delivered double-digit growth in active loyalty members, increased traffic and delivered double-digit growth in almost every key merchandise category,” said Ulta CEO Mary Dillon 29 August. However, worsening makeup trends have induced the firm to reset full-year targets.

In Brief

L’Oreal considers travel retail a “sixth continent” in terms of consumer reach and creates a new division to better serve the segment; firm separately announces it will shutter its mail-order division. More news in brief.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149196

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel